ISSN 0303-5212
 

Original Research 
RMJ. 2022; 47(4): 850-853


Carvedilol vs endoscopic band ligation: primary prophylaxis of variceal bleed

Nimra Kanwal, Samrina Sadaf, Nauman Ismat Butt, Hayida Ali Awan, Fahmina Ashfaq, Nousheen Zia.

Abstract
Objective: To compare variceal bleed in patients of liver cirrhosis receiving carvedilol versus esophageal band ligation as primary prophylaxis within three months of treatment.
Methodology: This randomized controlled trial was carried out at Department of Medicine, District Head Quarter Hospital, Rawalpindi from September 1st 2016 to February 28th 2017 with 254 patients of cirrhosis with esophageal varices. They were divided into 2 groups with 127 each: Carvedilol group and endoscopic band ligation. Data were recorded at baseline and at regular follow ups for three months or first variceal bleed. Data analysis was performed with SPSS 20. Effect modifiers and confounders were controlled through stratification and Chi Square test applied with p≤0.05 significant.
Results: Out of 254 patients, 188 (74.0%) were male and 66 (26.0%) females. Mean age was 55.60+9.01 years. Mean Child Pugh Score was 6.59+4.09. Frequency of variceal bleeding in patients receiving carvedilol was 35 (27.6%) compared to 27 (21.3%) of esophageal band ligation as primary prophylaxis within three months of treatment.
Conclusion: Variceal bleeding in liver cirrhosis patients taking carvedilol had no significant difference as opposed to esophageal band ligation and both regimens can be used for primary prophylaxis. Carvedilol is helpful in reduction of unnecessary endoscopy related expenditure and discomfort.

Key words: Carvedilol, endoscopic band ligation, cirrhosis, esophageal varies.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Nimra Kanwal
Articles by Samrina Sadaf
Articles by Nauman Ismat Butt
Articles by Hayida Ali Awan
Articles by Fahmina Ashfaq
Articles by Nousheen Zia
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Kanwal N, Sadaf S, Butt NI, Awan HA, Ashfaq F, Zia N. Carvedilol vs endoscopic band ligation: primary prophylaxis of variceal bleed. RMJ. 2022; 47(4): 850-853.


Web Style

Kanwal N, Sadaf S, Butt NI, Awan HA, Ashfaq F, Zia N. Carvedilol vs endoscopic band ligation: primary prophylaxis of variceal bleed. https://www.rmj.org.pk/?mno=100458 [Access: December 04, 2023].


AMA (American Medical Association) Style

Kanwal N, Sadaf S, Butt NI, Awan HA, Ashfaq F, Zia N. Carvedilol vs endoscopic band ligation: primary prophylaxis of variceal bleed. RMJ. 2022; 47(4): 850-853.



Vancouver/ICMJE Style

Kanwal N, Sadaf S, Butt NI, Awan HA, Ashfaq F, Zia N. Carvedilol vs endoscopic band ligation: primary prophylaxis of variceal bleed. RMJ. (2022), [cited December 04, 2023]; 47(4): 850-853.



Harvard Style

Kanwal, N., Sadaf, . S., Butt, . N. I., Awan, . H. A., Ashfaq, . F. & Zia, . N. (2022) Carvedilol vs endoscopic band ligation: primary prophylaxis of variceal bleed. RMJ, 47 (4), 850-853.



Turabian Style

Kanwal, Nimra, Samrina Sadaf, Nauman Ismat Butt, Hayida Ali Awan, Fahmina Ashfaq, and Nousheen Zia. 2022. Carvedilol vs endoscopic band ligation: primary prophylaxis of variceal bleed. Rawal Medical Journal, 47 (4), 850-853.



Chicago Style

Kanwal, Nimra, Samrina Sadaf, Nauman Ismat Butt, Hayida Ali Awan, Fahmina Ashfaq, and Nousheen Zia. "Carvedilol vs endoscopic band ligation: primary prophylaxis of variceal bleed." Rawal Medical Journal 47 (2022), 850-853.



MLA (The Modern Language Association) Style

Kanwal, Nimra, Samrina Sadaf, Nauman Ismat Butt, Hayida Ali Awan, Fahmina Ashfaq, and Nousheen Zia. "Carvedilol vs endoscopic band ligation: primary prophylaxis of variceal bleed." Rawal Medical Journal 47.4 (2022), 850-853. Print.



APA (American Psychological Association) Style

Kanwal, N., Sadaf, . S., Butt, . N. I., Awan, . H. A., Ashfaq, . F. & Zia, . N. (2022) Carvedilol vs endoscopic band ligation: primary prophylaxis of variceal bleed. Rawal Medical Journal, 47 (4), 850-853.